Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Myriad Genetics Inc.
DescriptionSecond-generation prognostic gene expression test for breast cancer
Molecular Target
Mechanism of Action 
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsPredict relapse in estrogen receptor-positive, HER2-negative primary breast cancer patients
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today